Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has shared an update.
Recordati S.p.A. has updated its shareholders on the progress of its share buyback program, which began on 30 April 2025. The company executed several purchase operations between 25 and 29 August 2025, acquiring a total of 54,614 shares at an average price of 52.6377 Euros per share. This initiative is part of Recordati’s strategy to service stock options and performance share plans for its management, enhancing its incentive plans and potentially impacting its market position.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR57.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange. Originating from a family-run pharmacy in Northern Italy, the company provides therapeutic options in general and specialist medicine, as well as rare diseases. Recordati operates in a fully integrated manner, from clinical development to the marketing and licensing of active ingredients and finished products, with a presence in about 150 countries across the EMEA, Americas, and APAC regions.
Average Trading Volume: 243,082
Technical Sentiment Signal: Strong Buy
Current Market Cap: €11B
See more insights into REC stock on TipRanks’ Stock Analysis page.